ID   MYCD_RAT                Reviewed;         938 AA.
AC   Q8R5I7; Q7M6Y4; Q8R5I8;
DT   27-JUN-2003, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2003, sequence version 2.
DT   29-MAY-2024, entry version 152.
DE   RecName: Full=Myocardin;
GN   Name=Myocd; Synonyms=Mycd;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Aorta;
RX   PubMed=12392995; DOI=10.1006/jmcc.2002.2086;
RA   Chen J., Kitchen C.M., Streb J.W., Miano J.M.;
RT   "Myocardin: a component of a molecular switch for smooth muscle
RT   differentiation.";
RL   J. Mol. Cell. Cardiol. 34:1345-1356(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 251-399.
RC   TISSUE=Aorta;
RX   PubMed=12663482; DOI=10.1161/01.res.0000068405.49081.09;
RA   Yoshida T., Sinha S., Dandre F., Wamhoff B.R., Hoofnagle M.H., Kremer B.E.,
RA   Wang D.-Z., Olson E.N., Owens G.K.;
RT   "Myocardin is a key regulator of CArG-dependent transcription of multiple
RT   smooth muscle marker genes.";
RL   Circ. Res. 92:856-864(2003).
RN   [3]
RP   SUBUNIT, AND MUTAGENESIS OF ILE-534; LEU-537 AND LEU-541.
RX   PubMed=12756293; DOI=10.1073/pnas.1232341100;
RA   Wang Z., Wang D.-Z., Pipes G.C., Olson E.N.;
RT   "Myocardin is a master regulator of smooth muscle gene expression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:7129-7134(2003).
RN   [4]
RP   FUNCTION, INTERACTION WITH STUB1, SUBCELLULAR LOCATION, UBIQUITINATION, AND
RP   PHOSPHORYLATION.
RX   PubMed=19237536; DOI=10.1128/mcb.01737-08;
RA   Xie P., Fan Y., Zhang H., Zhang Y., She M., Gu D., Patterson C., Li H.;
RT   "CHIP represses myocardin-induced smooth muscle cell differentiation via
RT   ubiquitin-mediated proteasomal degradation.";
RL   Mol. Cell. Biol. 29:2398-2408(2009).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=20385216; DOI=10.1016/j.gene.2010.03.012;
RA   Imamura M., Long X., Nanda V., Miano J.M.;
RT   "Expression and functional activity of four myocardin isoforms.";
RL   Gene 464:1-10(2010).
CC   -!- FUNCTION: Smooth muscle cells (SM) and cardiac muscle cells-specific
CC       transcriptional factor which uses the canonical single or multiple CArG
CC       boxes DNA sequence. Acts as a cofactor of serum response factor (SRF)
CC       with the potential to modulate SRF-target genes (By similarity). Plays
CC       a crucial role in cardiogenesis, urinary bladder development, and
CC       differentiation of the smooth muscle cell lineage (myogenesis) (By
CC       similarity). Positively regulates the transcription of genes involved
CC       in vascular smooth muscle contraction (PubMed:19237536). {ECO:0000250,
CC       ECO:0000269|PubMed:19237536}.
CC   -!- SUBUNIT: Homodimer. Interacts with MLLT7/FOXO4. Interacts with SRF, its
CC       association does not depend on specific DNA sequences for ternary
CC       complex formation (By similarity). Interacts (via C-terminal) with
CC       EP300 (via the CREB-binding domain). Interacts with HDAC4 and HDAC5 (By
CC       similarity). Interacts with MEF2C (By similarity). Interacts (via C-
CC       terminus) with STUB1/CHIP (PubMed:19237536). Interacts with PURB (By
CC       similarity). {ECO:0000250|UniProtKB:Q8IZQ8,
CC       ECO:0000250|UniProtKB:Q8VIM5, ECO:0000269|PubMed:19237536}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12392995,
CC       ECO:0000269|PubMed:19237536}.
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in the heart, aorta media and
CC       bladder, weakly expressed in the stomach, intestine and lung.
CC       {ECO:0000269|PubMed:20385216}.
CC   -!- DOMAIN: The C-terminal region contains a general transcription
CC       activation domain. The N-terminal region, comprising a basic and a Gln-
CC       rich domain, confers transcriptional potency and specificity by
CC       mediating association with the MADS box of SRF. The basic domain may be
CC       required for nuclear localization. The SAP domain is important for
CC       transactivation and ternary complex formation (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated; by STUB1/CHIP at the C-terminus, leading to its
CC       degradation by the proteasome (PubMed:19237536). Phosphorylation by
CC       GSK3B is required for STUB1/CHIP-mediated ubiquitination
CC       (PubMed:19237536). {ECO:0000269|PubMed:19237536}.
CC   -!- PTM: Phosphorylation negatively regulates transcriptional activity (By
CC       similarity). Phosphorylated; by GSK3B (PubMed:19237536).
CC       {ECO:0000250|UniProtKB:Q8VIM5, ECO:0000269|PubMed:19237536}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF464909; AAL75447.1; -; mRNA.
DR   EMBL; AF464910; AAL75446.1; -; mRNA.
DR   EMBL; AB091378; BAC65150.1; -; mRNA.
DR   EMBL; BK001422; DAA01467.1; -; mRNA.
DR   RefSeq; NP_872608.1; NM_182667.2.
DR   AlphaFoldDB; Q8R5I7; -.
DR   SMR; Q8R5I7; -.
DR   CORUM; Q8R5I7; -.
DR   STRING; 10116.ENSRNOP00000072988; -.
DR   PhosphoSitePlus; Q8R5I7; -.
DR   PaxDb; 10116-ENSRNOP00000054372; -.
DR   Ensembl; ENSRNOT00000057562.4; ENSRNOP00000054372.2; ENSRNOG00000003669.8.
DR   Ensembl; ENSRNOT00055054854; ENSRNOP00055045336; ENSRNOG00055031666.
DR   Ensembl; ENSRNOT00060044636; ENSRNOP00060036991; ENSRNOG00060025678.
DR   GeneID; 246297; -.
DR   KEGG; rno:246297; -.
DR   UCSC; RGD:631347; rat.
DR   AGR; RGD:631347; -.
DR   CTD; 93649; -.
DR   RGD; 631347; Myocd.
DR   eggNOG; ENOG502QTAN; Eukaryota.
DR   GeneTree; ENSGT00950000182979; -.
DR   HOGENOM; CLU_007042_2_0_1; -.
DR   InParanoid; Q8R5I7; -.
DR   OrthoDB; 2997330at2759; -.
DR   PhylomeDB; Q8R5I7; -.
DR   TreeFam; TF326024; -.
DR   PRO; PR:Q8R5I7; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000003669; Expressed in heart and 10 other cell types or tissues.
DR   ExpressionAtlas; Q8R5I7; baseline and differential.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032993; C:protein-DNA complex; IDA:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0035035; F:histone acetyltransferase binding; ISO:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:RGD.
DR   GO; GO:0070412; F:R-SMAD binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:RGD.
DR   GO; GO:0010659; P:cardiac muscle cell apoptotic process; ISO:RGD.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; ISO:RGD.
DR   GO; GO:0060379; P:cardiac muscle cell myoblast differentiation; ISO:RGD.
DR   GO; GO:0060947; P:cardiac vascular smooth muscle cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0003231; P:cardiac ventricle development; ISO:RGD.
DR   GO; GO:0061049; P:cell growth involved in cardiac muscle cell development; IMP:RGD.
DR   GO; GO:0043954; P:cellular component maintenance; ISO:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; IEP:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0006325; P:chromatin organization; ISO:RGD.
DR   GO; GO:0048565; P:digestive tract development; ISO:RGD.
DR   GO; GO:0097070; P:ductus arteriosus closure; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0035733; P:hepatic stellate cell activation; IMP:RGD.
DR   GO; GO:0048286; P:lung alveolus development; ISO:RGD.
DR   GO; GO:1900222; P:negative regulation of amyloid-beta clearance; ISO:RGD.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; ISO:RGD.
DR   GO; GO:0060354; P:negative regulation of cell adhesion molecule production; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; ISO:RGD.
DR   GO; GO:2000587; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; ISO:RGD.
DR   GO; GO:2001015; P:negative regulation of skeletal muscle cell differentiation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:1904753; P:negative regulation of vascular associated smooth muscle cell migration; ISO:RGD.
DR   GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:2000727; P:positive regulation of cardiac muscle cell differentiation; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:1902895; P:positive regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0051152; P:positive regulation of smooth muscle cell differentiation; ISO:RGD.
DR   GO; GO:0045987; P:positive regulation of smooth muscle contraction; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:1904754; P:positive regulation of vascular associated smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0001560; P:regulation of cell growth by extracellular stimulus; ISO:RGD.
DR   GO; GO:0045661; P:regulation of myoblast differentiation; ISO:RGD.
DR   GO; GO:1900239; P:regulation of phenotypic switching; ISO:RGD.
DR   GO; GO:0051150; P:regulation of smooth muscle cell differentiation; IMP:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0035994; P:response to muscle stretch; IEP:RGD.
DR   GO; GO:0051145; P:smooth muscle cell differentiation; IMP:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045815; P:transcription initiation-coupled chromatin remodeling; ISS:UniProtKB.
DR   GO; GO:0060157; P:urinary bladder development; ISO:RGD.
DR   GO; GO:0060065; P:uterus development; ISO:RGD.
DR   GO; GO:0035886; P:vascular associated smooth muscle cell differentiation; ISO:RGD.
DR   GO; GO:0001570; P:vasculogenesis; ISO:RGD.
DR   GO; GO:0055012; P:ventricular cardiac muscle cell differentiation; ISO:RGD.
DR   Gene3D; 6.10.140.2040; -; 1.
DR   Gene3D; 6.10.150.10; -; 1.
DR   Gene3D; 1.10.720.30; SAP domain; 1.
DR   InterPro; IPR043451; Myocardin-like.
DR   InterPro; IPR004018; RPEL_repeat.
DR   InterPro; IPR003034; SAP_dom.
DR   InterPro; IPR036361; SAP_dom_sf.
DR   PANTHER; PTHR22793:SF11; MYOCARDIN; 1.
DR   PANTHER; PTHR22793; MYOCARDIN-RELATED TRANSCRIPTION FACTOR-RELATED; 1.
DR   Pfam; PF02755; RPEL; 1.
DR   Pfam; PF02037; SAP; 1.
DR   SMART; SM00707; RPEL; 3.
DR   SMART; SM00513; SAP; 1.
DR   SUPFAM; SSF68906; SAP domain; 1.
DR   PROSITE; PS51073; RPEL; 3.
DR   PROSITE; PS50800; SAP; 1.
PE   1: Evidence at protein level;
KW   Activator; Coiled coil; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..938
FT                   /note="Myocardin"
FT                   /id="PRO_0000126633"
FT   REPEAT          18..43
FT                   /note="RPEL 1"
FT   REPEAT          62..87
FT                   /note="RPEL 2"
FT   REPEAT          106..131
FT                   /note="RPEL 3"
FT   DOMAIN          383..417
FT                   /note="SAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00186"
FT   REGION          37..64
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          153..205
FT                   /note="HDAC5-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          155..282
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          339..381
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          501..521
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          586..606
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          667..734
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          717..938
FT                   /note="Required for interaction with and ubiquitination by
FT                   STUB1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   COILED          522..566
FT                   /evidence="ECO:0000255"
FT   MOTIF           12..27
FT                   /note="MEF2C-binding"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        46..64
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        168..182
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        198..225
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        339..375
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        586..605
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         457
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MOD_RES         461
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MOD_RES         465
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MOD_RES         469
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MOD_RES         627
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MOD_RES         631
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MOD_RES         635
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MOD_RES         639
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MOD_RES         815
FT                   /note="Phosphoserine; by MAPK1 and MAPK3"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MOD_RES         862
FT                   /note="Phosphoserine; by MAPK1 and MAPK3"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MOD_RES         869
FT                   /note="Phosphoserine; by MAPK1 and MAPK3"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MOD_RES         896
FT                   /note="Phosphothreonine; by MAPK1 and MAPK3"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIM5"
FT   MUTAGEN         534
FT                   /note="I->T: Abolishes homodimerization."
FT                   /evidence="ECO:0000269|PubMed:12756293"
FT   MUTAGEN         537
FT                   /note="L->T: Abolishes homodimerization."
FT                   /evidence="ECO:0000269|PubMed:12756293"
FT   MUTAGEN         541
FT                   /note="L->T: Abolishes homodimerization."
FT                   /evidence="ECO:0000269|PubMed:12756293"
SQ   SEQUENCE   938 AA;  101872 MW;  C64F10796AD53618 CRC64;
     MTLLGSEHSL LIRRKFRSVL QLRLQQRRTQ EQLANQGLIP PLKSPTEFHD PRKKLDSAKT
     EDSLRRKVRN RSDRASLVNM HILQASTAER SIPTAQMKLK RARLADDLNE KIALRPGPLE
     LVEKNILPMD SSVKEAIKGT EVSLSKAADA FAFEDDSSRD GLSPDQARSE DPQGSGGSTP
     DIKSTEAPLA GPLDTIQDLT PGSESDKNDT ASQLSNQSDS GKQVLGPLST PIPVHTAVKS
     KSLGDSKNRH KKPKDPKPKV KKLKYHQYIP PDQKAEKSPP PMDSAYARLL QQQQLFLQLQ
     ILSQQQQQQQ QQQQQQQQQQ QQQRFSYPGM HQAHLKEPNE QMTRNPNSSS TPLNNTPLSP
     VKNSLSGQTG VSSLKPGPLP PNLDDLKVSE LRQQLRIRGL PVSGTKTALV DRLRPFQDCA
     GNPVPNFGDI TTVTFPVTPN TLPSYQSSPS GFYHFGSTSS SPPISPASSD LSAAGSLPDT
     FTDASPGFGL HASPVPACTD ESLLSSLNGG SGPSEPDGLD SEKDKMLVEK QKVINQLTWK
     LRQEQRQVEE LRMQLQKQKS GCNDQKPLPF LATTIKQEDV SSCPFAAQQA SGKGQGHSSD
     SPPPACETAQ LLPHCVESSG QTHVLSSTFL SPQCSPQHSP LGTLKSPQHI SLPPSPNNHY
     FLASSSGAQR ENHGVSSPNS SQGCAQMTGL QSSDKVGPTF SIPSPTFPKS SPTVPEITQP
     PSYEDAVKQQ MTRSQQMDEL LDVLIESGEM PADAREDHSC LQKIPKIPGS SCSPTTILPK
     SSASFEQASS GGQISFDHYA TDSEEHLEVL LNSHSPIGKV SDVTLLKIGS EEPPFDGIMD
     GFPGKAAEDL FSAHELLPGP LSPMHTQLSP PSVDSSGLQL SFTESPWETM EWLDLTPPSS
     TPGFSNLTSS GPSIFNIDFL DVTDLNLNSP MDLHLQQW
//
